| Title : Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial - Henderson_2016_Lancet.Neurol_15_249 |
| Author(s) : Henderson EJ , Lord SR , Brodie MA , Gaunt DM , Lawrence AD , Close JC , Whone AL , Ben-Shlomo Y |
| Ref : Lancet Neurol , 15 :249 , 2016 |
| Abstract : |
| PubMedSearch : Henderson_2016_Lancet.Neurol_15_249 |
| PubMedID: 26795874 |
| Title : The ReSPonD trial - rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen - Henderson_2013_BMC.Neurol_13_188 |
| Author(s) : Henderson EJ , Lord SR , Close JC , Lawrence AD , Whone A , Ben-Shlomo Y |
| Ref : BMC Neurol , 13 :188 , 2013 |
| Abstract : |
| PubMedSearch : Henderson_2013_BMC.Neurol_13_188 |
| PubMedID: 24299497 |